Publications by authors named "Hoi Ching Chan"

Claim this Profile
A
Anti-PD1 does not improve pyroptosis induced by γδ T cells but promotes tumor regression in a pleural mesothelioma mouse model.
Ka Sin Lui, Zuodong Ye, Hoi Ching Chan, Yoshimasa Tanaka, Allen Ka Loon Cheung

Front Immunol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficient co-delivery of a Pt(IV) prodrug and a p53 activator to enhance the anticancer activity of cisplatin.
Rong Ma, Yiping Wang, Li Yan, Lili Ma, Zhigang Wang, Hoi Ching Chan

Chem Commun (Camb)· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chalcoplatin, a dual-targeting and p53 activator-containing anticancer platinum(IV) prodrug with unique mode of action.
Lili Ma, Rong Ma, Yiping Wang, Xiaoyue Zhu, Junliang Zhang, Hoi Ching Chan

Chem Commun (Camb)· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis